Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
7503790 | Drug and Alcohol Dependence | 2016 | 36 Pages |
Abstract
These results show that RewP amplitude in response to rewarded trials tracks state anhedonia severity in iCUD. We argue that this association is perhaps driven by the activity in the dopaminergic mesocorticolimbic reward pathway that may underlie anhedonia symptomology as well as modulate RewP amplitude.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Muhammad A. Parvaz, Vilma Gabbay, Pias Malaker, Rita Z. Goldstein,